Home
Conditions
Chemically-Induced Disorders

Clinical trial condition

Chemically-Induced Disorders

Explore clinical trials studying Chemically-Induced Disorders. Study availability and eligibility vary by location and protocol.

7,320 public trials 1,007 recruiting studies

Refine in advanced search Browse all conditions

Chemically-Induced Disorders trial results

Completed

Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

NCT00032929

Conditions: Chemically-Induced Disorders, Cocaine-Related Disorders, Mental Disorders, +1 more
Locations: Tucson VA Medical Center Tucson, Arizona, United States

Haight-Ashbury Free Clinic Berkeley, California, United States

Friends Research Institute-2 Los Angeles, California, United States

Friends Research Institute Los Angeles, California, United States

View all 16 locations

View Trial Details

Completed

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1

NCT00218517

Conditions: Chemically-Induced Disorders, Marijuana Abuse, Mental Disorders, +1 more
Locations: MRU New Haven, Connecticut, United States

View Trial Details

Completed

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

NCT00000274

Conditions: Chemically-Induced Disorders, Cocaine-Related Disorders, Mental Disorders, +2 more
Locations: New York State Psychiatric Institute New York, United States

View Trial Details

Completed

Ph1 Marinol Interaction Study - Part 2 - 1

NCT00490269

Conditions: Chemically-Induced Disorders, Marijuana Abuse, Marijuana Dependence, +2 more
Locations: Uniformed Services University of Health Science Bethesda, Maryland, United States

View Trial Details

Completed

Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients

NCT00060814

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +1 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

Progesterone Treatment in Female Smokers - 12

NCT00000295

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +1 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

NCT00015041

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations: Cincinnati MDRU Cincinnati, Ohio, United States

View Trial Details

Completed

Maintaining Abstinence in Chronic Cigarette Smokers - 1

NCT00087880

Conditions: Behavior, Chemically-Induced Disorders, Health Behavior, +4 more
Locations: University California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome

NCT00521248

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Role of Metabolites in Nicotine Dependence (1) - 1

NCT00000284

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +1 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Chemically-Induced Disorders

Chemically-Induced Disorders trial results

Related conditions